Study to Evaluate the Efficacy, Tolerability and Safety of Octanorm in Patients With Primary Immunodeficiency Diseases

The State Research Center, Institute of Immunology of the Federal Medical-Biological Agency, Moscow

Federal Research Center of Pediatric Hematology, Oncology and Immunology of the Ministry of Health and Social Development of the Russian Federation, Moscow

Pasteur Institute, Saint Petersburg

State Medical University, Rostov

Institute of Immunology and Physiology of the Ural Branch of the Russian Academy of sciences, Yekaterinburg